Treatment options for chronic low back pain and chronic pain in general are quite limited. The opioid crisis has led to a sharp reduction of the utilization such therapies for chronic pain.
The founders identified a market need illustrated by a combination of factors including the prevalence of chronic pain, the commercial success of Lidoderm® patches.